Adult T-cell leukemia (ATL) cells contain integrated human T-cell leukemia virus type 1
(HTLV-1) proviruses. Although the exact sequence of events leading to the development of …

Human T cell leukemia virus type 1 (HTLV-1) was identified as the first pathogenic human
retrovirus and is estimated to infect 5 to 10 million individuals worldwide. Unlike other …

Background Human T-cell leukemia virus types 1 and 2 (HTLV-1 and HTLV-2) are delta
retroviruses with similar genetic organization. Although both viruses immortalize T-cells in …

HTLV-1 causes ATLL in 3-5% of infected individuals after a long latent period of 40-60
years. ATLL is divided into four stages: namely, smoldering, chronic, lymphoma and acute …

Infection with the Human T-cell Leukemia virus type I (HTLV-1) retrovirus results in a number
of diverse pathologies, including the aggressive, fatal T-cell malignancy adult T-cell …

Background: This study was performed to identify key regulatory network biomarkers
including transcription factors (TFs), miRNAs and lncRNAs that may affect the oncogenesis …

Human T-cell leukemia virus type 1 (HTLV-1) is a complex retrovirus etiologically linked with
adult T-cell leukemia/lymphoma (ATL), HTLV-1–associated myelopathy/tropical spastic …

Adult T cell leukemia/lymphoma (ATL) is a neoplasm linked to human T-lymphotropic virus
type-1 (HTLV-1) infection and is refractory to current combination chemotherapy. A large …

Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL).
HTLV-1 carriers have a lifelong asymptomatic balance between infected cells and host …

Human T cell leukemia virus types 1 and 2 (HTLV‐1 and HTLV‐2) are genetically related
complex retroviruses that are capable of immortalizing human T‐cells in vitro and establish …